Product name | Per Pill | Savings | Per Pack | Order |
---|---|---|---|---|
30 pills | $2.31 | $69.35 | Buy Now | |
60 pills | $1.83 | $28.87 | $138.70 $109.83 | Buy Now |
90 pills | $1.67 | $57.73 | $208.04 $150.31 | Buy Now |
120 pills | $1.59 | $86.60 | $277.39 $190.79 | Buy Now |
180 pills | $1.51 | $144.33 | $416.08 $271.75 | Buy Now |
270 pills | $1.46 | $230.92 | $624.11 $393.19 | Buy Now |
Product name | Per Pill | Savings | Per Pack | Order |
---|---|---|---|---|
30 pills | $1.55 | $46.35 | Buy Now | |
60 pills | $1.22 | $19.72 | $92.70 $72.98 | Buy Now |
90 pills | $1.11 | $39.44 | $139.06 $99.62 | Buy Now |
120 pills | $1.05 | $59.16 | $185.41 $126.25 | Buy Now |
180 pills | $1.00 | $98.60 | $278.11 $179.51 | Buy Now |
270 pills | $0.96 | $157.77 | $417.18 $259.41 | Buy Now |
360 pills | $0.94 | $216.93 | $556.23 $339.30 | Buy Now |
Product name | Per Pill | Savings | Per Pack | Order |
---|---|---|---|---|
30 pills | $1.08 | $32.48 | Buy Now | |
60 pills | $0.85 | $14.17 | $64.95 $50.78 | Buy Now |
90 pills | $0.77 | $28.34 | $97.43 $69.09 | Buy Now |
120 pills | $0.73 | $42.52 | $129.92 $87.40 | Buy Now |
180 pills | $0.69 | $70.86 | $194.87 $124.01 | Buy Now |
270 pills | $0.66 | $113.38 | $292.31 $178.93 | Buy Now |
360 pills | $0.65 | $155.90 | $389.75 $233.85 | Buy Now |
Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation associated with various conditions such as arthritis, gout, and postoperative pain. It works by reducing hormones that cause inflammation and pain in the body. Etodolac is available in various formulations, including immediate-release tablets, extended-release tablets, and capsules, providing flexible treatment options for different patient needs.
Etodolac offers several key benefits for patients with pain and inflammation:
Etodolac is distinguished by its selective inhibition of the cyclooxygenase-2 (COX-2) enzyme, which reduces the risk of gastrointestinal side effects commonly associated with other NSAIDs. Its unique chemical structure also provides a longer duration of action, making it suitable for once or twice-daily dosing.
Compared to other NSAIDs, Etodolac offers unique advantages:
Etodolac is generally well-tolerated when used as directed. Common side effects include stomach pain, nausea, and dizziness. Serious side effects are rare but may include cardiovascular events, gastrointestinal bleeding, and liver toxicity. Regular monitoring by a healthcare provider is recommended to ensure safety and efficacy.
Etodolac is prescribed for the treatment of various conditions, including:
Patients experiencing symptoms of pain and inflammation, such as joint pain, swelling, stiffness, and tenderness, may benefit from Etodolac. It is particularly effective for managing chronic pain conditions and acute inflammatory episodes.
The dosage of Etodolac varies depending on the formulation and the condition being treated:
Etodolac is not commonly prescribed for children. Pediatric dosing should be guided by a healthcare provider, especially considering the risk of side effects and the need for careful monitoring.
Elderly patients may require lower doses of Etodolac due to increased susceptibility to side effects and potential comorbidities. It is important to start at a lower dose and adjust based on therapeutic response and tolerance.
Etodolac can be taken with or without food. Taking it with food or milk may help reduce gastrointestinal side effects. Extended-release tablets are typically taken once daily, preferably at the same time each day.
Food does not significantly impact the efficacy of Etodolac, but taking it with food can help minimize gastrointestinal discomfort. Patients should follow their healthcare provider's instructions regarding food intake and medication timing.
Etodolac works by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme, which reduces the synthesis of prostaglandins involved in inflammation, pain, and fever. This inhibition leads to decreased inflammation and pain relief.
Etodolac targets the COX-2 enzyme in the body, reducing the production of prostaglandins that mediate inflammation and pain. By inhibiting COX-2, Etodolac provides anti-inflammatory and analgesic effects.
Etodolac is metabolized primarily in the liver by the cytochrome P450 enzyme system. Its metabolites are excreted primarily in the urine, with a small portion excreted in the feces.
Inhibition of COX-2 by Etodolac leads to reduced levels of prostaglandins, which are mediators of inflammation and pain. This biochemical change results in decreased inflammation, pain relief, and improved function in patients with inflammatory conditions.
By reducing inflammation and pain, Etodolac helps improve mobility, reduce discomfort, and enhance the quality of life for patients with various inflammatory conditions. It provides significant relief from symptoms, allowing patients to engage in daily activities with less pain and stiffness.
The active ingredient in Etodolac is etodolac. It is available in various forms, including immediate-release tablets, extended-release tablets, and capsules.
Etodolac acts as the primary anti-inflammatory and analgesic agent, while inactive ingredients aid in the formulation, stability, and absorption of the medication. They ensure proper delivery of the active ingredient to achieve therapeutic effects.
Common side effects of Etodolac include stomach pain, nausea, vomiting, diarrhea, dizziness, and headache. These side effects are usually mild and may decrease with continued use of the medication.
Rare side effects may include severe allergic reactions, liver toxicity, kidney damage, and cardiovascular events. Patients should seek medical attention if they experience symptoms such as rash, yellowing of the skin or eyes, dark urine, severe abdominal pain, or chest pain.
Serious side effects requiring immediate medical attention include signs of liver damage (jaundice, dark urine, severe abdominal pain), severe allergic reactions (rash, itching/swelling, severe dizziness, trouble breathing), and cardiovascular events (chest pain, shortness of breath, weakness on one side of the body).
Most side effects are mild and occur early in the treatment. Serious side effects are rare but warrant close monitoring by a healthcare provider. Regular follow-up appointments can help manage and mitigate these risks, ensuring safe and effective use of Etodolac.
To minimize side effects, patients should follow the prescribed dosage and avoid using Etodolac for longer than recommended. Regular monitoring of liver function, kidney function, and blood pressure is advised for patients taking Etodolac, especially with long-term use.
Using Etodolac as directed and maintaining regular follow-up appointments with a healthcare provider can improve tolerability. Patients should be educated on the importance of adhering to the prescribed treatment regimen and monitoring their response to the medication. Taking Etodolac with food can help reduce gastrointestinal side effects.
Etodolac is contraindicated in patients with known hypersensitivity to etodolac or any of its components. It should not be used in patients with active gastrointestinal bleeding, peptic ulcer disease, severe liver or kidney disease, or a history of cardiovascular events.
Etodolac may exacerbate certain conditions, such as gastrointestinal bleeding, due to its effect on COX-2 inhibition. Hypersensitivity reactions can cause severe allergic responses, making it crucial to assess a patient's medical history and allergies before prescribing Etodolac.
Patients should be monitored for signs of gastrointestinal bleeding, liver toxicity, kidney damage, and cardiovascular events, especially those with pre-existing conditions. Regular blood tests may be required to monitor liver and kidney function and blood pressure.
Regular monitoring by a healthcare provider, starting with a low dose, and adjusting as needed can help mitigate risks. Patients should be instructed to report any symptoms of gastrointestinal bleeding, severe allergic reactions, or cardiovascular events.
If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. Do not double the dose to catch up. Continue with the regular dosing schedule.
Using reminders and keeping a consistent schedule can help prevent missed doses. Patients can set alarms, use medication reminder apps, or keep a medication diary to track their doses.
Etodolac may interact with other medications, including certain anticoagulants, antihypertensives, and other NSAIDs. These interactions can either reduce the efficacy of Etodolac or increase the risk of adverse effects. It is essential to inform the healthcare provider of all medications being taken to avoid potential interactions.
These interactions can affect the metabolism and efficacy of Etodolac or the concomitant medications. For instance, certain drugs can increase the risk of gastrointestinal bleeding or reduce the effectiveness of Etodolac. Monitoring blood levels and adjusting dosages may be necessary to manage these interactions.
Inform the healthcare provider of all medications being taken to avoid potential interactions. Patients should not start, stop, or change the dosage of any medicines without their healthcare provider’s approval. Regular reviews of medication regimens can help identify and manage potential interactions.
Symptoms of overdose may include severe stomach pain, vomiting, drowsiness, and difficulty breathing. Seek emergency medical help if an overdose is suspected. Supportive measures and symptomatic treatment are recommended.
Seek emergency medical help if an overdose is suspected. Supportive measures and symptomatic treatment are recommended. Activated charcoal may be administered if the overdose is recent, and intravenous fluids may be given to maintain blood pressure.
Etodolac is well-absorbed from the gastrointestinal tract, with peak plasma concentrations reached within 1 to 2 hours after oral administration. The bioavailability of Etodolac is approximately 80%.
Etodolac is widely distributed throughout the body, with a volume of distribution of about 0.4 to 1.2 liters per kilogram. It is highly bound to plasma proteins, primarily albumin.
Etodolac is extensively metabolized in the liver by the cytochrome P450 enzyme system. Its metabolites are excreted primarily in the urine, with a small portion excreted in the feces.
The half-life of Etodolac is approximately 6 to 7 hours. Dose adjustments may be necessary for patients with liver or kidney impairment to prevent accumulation and toxicity.
Etodolac is available in immediate-release tablets (200 mg, 300 mg, 400 mg), extended-release tablets (400 mg, 500 mg, 600 mg), and capsules (200 mg, 300 mg). These various forms and dosages allow for flexible and tailored treatment approaches based on patient needs and tolerability.
The availability of multiple forms of Etodolac makes it suitable for various patient preferences and clinical situations. Immediate-release formulations provide rapid pain relief, while extended-release forms offer sustained pain control with less frequent dosing.
Etodolac should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. There is limited data on the use of Etodolac in pregnant women, and NSAIDs are generally avoided during the third trimester due to the risk of premature closure of the ductus arteriosus. Pregnant women should discuss the potential risks and benefits with their healthcare provider before starting treatment.
It is not known whether Etodolac is excreted in human milk. Due to the potential for adverse reactions in nursing infants, a decision should be made whether to discontinue breastfeeding or discontinue the drug, considering the importance of the drug to the mother. Breastfeeding mothers should consult their healthcare provider to weigh the potential risks and benefits.
Store Etodolac at room temperature between 20°C to 25°C (68°F to 77°F). Keep the medication in its original container, tightly closed, and out of reach of children and pets.
Etodolac tablets and capsules should be stored in a cool, dry place away from direct sunlight and moisture. Extended-release tablets should be stored according to the manufacturer's instructions, usually in their original packaging to protect them from light and moisture.
Check the expiration date on the package and do not use Etodolac past the expiration date. Proper storage ensures the medication remains effective and safe to use. Dispose of expired or unused medication according to local regulations to prevent accidental exposure or misuse.
Etodolac has undergone extensive clinical trials to evaluate its safety and efficacy in treating various pain and inflammatory conditions. These studies included randomized, double-blind, placebo-controlled trials involving thousands of patients worldwide.
Clinical trials have shown that Etodolac significantly reduces pain and inflammation in patients with conditions such as osteoarthritis, rheumatoid arthritis, and acute pain. Patients treated with Etodolac demonstrated better outcomes in terms of pain relief and improved function compared to those receiving a placebo.
Studies comparing Etodolac with other NSAIDs have shown that Etodolac provides effective pain and inflammation relief with a favorable safety profile. Its selective COX-2 inhibition and extended duration of action make it a preferred choice for many healthcare providers.
Etodolac is an effective NSAID for treating a variety of pain and inflammatory conditions. Its selective COX-2 inhibition and extended duration of action provide significant benefits for patients with chronic and acute pain. The medication is generally well-tolerated, with a well-documented safety profile.
For optimal results, patients should follow their healthcare provider's instructions regarding dosage and administration. Regular monitoring and follow-up appointments are essential to ensure the medication's effectiveness and manage any side effects. Patients should maintain a healthy lifestyle, including a balanced diet and regular exercise, to support overall health while on Etodolac therapy.
Etodolac significantly improves the quality of life for patients with pain and inflammatory conditions by effectively managing symptoms and reducing the frequency and severity of pain. With its proven efficacy and safety, Etodolac remains a trusted choice for healthcare providers and patients in the management of various pain conditions.